Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 1Sanofi
02 1Dr. Reddy's Laboratories
03 1Sichuan Elixir Pharmaceuticals
04 1TAPI Technology & API Services
05 1Hetero Drugs
06 1Indena
07 1Intas Pharmaceuticals
08 1Laurus Labs
09 1Lunan Pharmaceutical
10 2MSN Laboratories
11 2Polymed Therapeutics Inc.
12 1Qilu Pharmaceutical
13 1Shilpa Medicare
14 1Sichuan Xieli Pharmaceutical
15 1Tianjin Weijie Pharmaceutical Co., Ltd.
16 1Yung Shin Pharmaceutical Industrial
01 11CABAZITAXEL
02 1CABAZITAXEL "YUNG SHIN"
03 1CABAZITAXEL (AMORPHOUS)
04 1CABAZITAXEL ACETONE SOLVATE
05 1CABAZITAXEL ETHYL ACETATE SOLVATE DRUG SUBSTANCE
06 1CABAZITAXEL MONOHYDRATE DRUG SUBSTANCE
07 1CABAZITAXEL [ROUTE CODE "CZ"]
08 1CABAZITAXEL [ROUTE CODE - ''CL'']
01 6China
02 1France
03 7India
04 1Israel
05 1Italy
06 2U.S.A
01 16Active
02 2Inactive
01 11Complete
02 7Blank
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 23496
Submission : 2010-01-29
Status : Active
Type : II
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Complete
Rev. Date : 2014-06-17
Pay. Date : 2014-03-20
DMF Number : 27895
Submission : 2014-02-18
Status : Active
Type : II
Sichuan Elixir Pharmaceutical, a manufacturer of small molecule APIs & a CMO/CDMO service provider for anti-tumor characteristic APIs..
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39645
Submission : 2024-03-26
Status : Active
Type : II
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
GDUFA
DMF Review : Complete
Rev. Date : 2014-06-02
Pay. Date : 2014-03-19
DMF Number : 28101
Submission : 2014-04-01
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2014-07-15
Pay. Date : 2014-04-16
DMF Number : 28159
Submission : 2014-04-21
Status : Active
Type : II
